Introduction P. Burney
... important cost driver in the healthcare system and may account for three-quarters of the additional costs of a patient with COPD. With the lack of good alternative remedies, such an effect would clearly be important not only to patients but also to the health services. Much of the new evidence comes ...
... important cost driver in the healthcare system and may account for three-quarters of the additional costs of a patient with COPD. With the lack of good alternative remedies, such an effect would clearly be important not only to patients but also to the health services. Much of the new evidence comes ...
asthma - Academy of Healing Nutrition
... severity of the disease, and help in planning treatment. Chest pain, shortness of breath (dyspnea), cough, coughing up of blood (hemoptysis), wheezing, and a crowing sound while breathing (stridor) suggest lung or airway disease. Other, more general symptoms, such as fever, weakness, fatigue, and a ...
... severity of the disease, and help in planning treatment. Chest pain, shortness of breath (dyspnea), cough, coughing up of blood (hemoptysis), wheezing, and a crowing sound while breathing (stridor) suggest lung or airway disease. Other, more general symptoms, such as fever, weakness, fatigue, and a ...
Zyprexa - Eli Lilly and Company
... drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest ...
... drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest ...
Basic Life Support Patient Care Standards (Version 2.0)
... a) to ensure that patient care is appropriate, safe, timely and efficient; b) to allow paramedics to exercise judgement as required by the situation; c) to account for the many diverse and adverse scene conditions which may, in some instances, alter the care provided to patients suffering from th ...
... a) to ensure that patient care is appropriate, safe, timely and efficient; b) to allow paramedics to exercise judgement as required by the situation; c) to account for the many diverse and adverse scene conditions which may, in some instances, alter the care provided to patients suffering from th ...
The value of community pharmacy - London
... On top of this, we estimate that indirect health system cost savings could be worth up to a further £2.5 billion in 2015 from the knock-on effects of self-care and medicines support. Apportioning the single year net benefit evenly across all the 11,815 pharmacies which operated in England at the end ...
... On top of this, we estimate that indirect health system cost savings could be worth up to a further £2.5 billion in 2015 from the knock-on effects of self-care and medicines support. Apportioning the single year net benefit evenly across all the 11,815 pharmacies which operated in England at the end ...
Free PDF - European Review for Medical and
... Atrial fibrillation is a strong risk factor for ischaemic stroke (approximately 3- to 5-fold excess risk), with associated clinical problems and increased mortality rates (1.5- to 1.9-fold mortality risk)2-4,6. Together with its complications, atrial fibrillation is a major cause of health care cons ...
... Atrial fibrillation is a strong risk factor for ischaemic stroke (approximately 3- to 5-fold excess risk), with associated clinical problems and increased mortality rates (1.5- to 1.9-fold mortality risk)2-4,6. Together with its complications, atrial fibrillation is a major cause of health care cons ...
Systemic effects of salbutamol and salmeterol in patients
... response to single doses of salmeterol was compared with that of cumulative doses of salbutamol, different delivery devices were used for salmeterol and salbutamol, and only one measurement was made after salmeterol so that the peak effect may have been missed. We therefore carried out a dose-respon ...
... response to single doses of salmeterol was compared with that of cumulative doses of salbutamol, different delivery devices were used for salmeterol and salbutamol, and only one measurement was made after salmeterol so that the peak effect may have been missed. We therefore carried out a dose-respon ...
VENTOLIN HFA Inhalation Aerosol prescribing
... asthma 12 years of age and older were treated with VENTOLIN HFA 2 inhalations 4 times daily for 12 weeks’ duration. The adult/adolescent population was 92 female, 110 male and 163 white, 19 black, 18 Hispanic, 2 other. The data from pediatric patients are based upon 1 clinical trial in which 46 pati ...
... asthma 12 years of age and older were treated with VENTOLIN HFA 2 inhalations 4 times daily for 12 weeks’ duration. The adult/adolescent population was 92 female, 110 male and 163 white, 19 black, 18 Hispanic, 2 other. The data from pediatric patients are based upon 1 clinical trial in which 46 pati ...
Data Sheet Name of Medicine Presentation
... euphoric effects of opioid in both volunteer and addict populations. When administered by means that enforce compliance, it will produce an effective opioid blockade, but has not been shown to affect the use of cocaine or other non-opioid drugs of abuse. There are no data that demonstrated an unequi ...
... euphoric effects of opioid in both volunteer and addict populations. When administered by means that enforce compliance, it will produce an effective opioid blockade, but has not been shown to affect the use of cocaine or other non-opioid drugs of abuse. There are no data that demonstrated an unequi ...
Product Monograph - Ask Novartis Pharma
... The frequency of adverse reactions to TOBI PODHALER progressively decreased over treatment cycles. The most frequent reactions in the TOBI PODHALER arm during the first cycle were: cough, dysphonia, productive cough and oropharyngeal pain; their frequency decreased over the study duration. Patients ...
... The frequency of adverse reactions to TOBI PODHALER progressively decreased over treatment cycles. The most frequent reactions in the TOBI PODHALER arm during the first cycle were: cough, dysphonia, productive cough and oropharyngeal pain; their frequency decreased over the study duration. Patients ...
The Eleventh Annual Controversies in Dialysis Access
... Hemodialysis central venous catheter (CVC) placement rates and duration of use have increased over the last 2 decades. Up to 80% of North American patients initiate hemodialysis with a CVC, and one third continue to use catheters 90 or more days after dialysis initiation. National guidelines recomme ...
... Hemodialysis central venous catheter (CVC) placement rates and duration of use have increased over the last 2 decades. Up to 80% of North American patients initiate hemodialysis with a CVC, and one third continue to use catheters 90 or more days after dialysis initiation. National guidelines recomme ...
NALTREXONE HYDROCHLORIDE TABLETS USP 50 mg Rx only
... controlled study in which naltrexone hydrochloride was administered to obese subjects at a dose approximately five-fold that recommended for the blockade of opiate receptors (300 mg per day). In that study, 5 of 26 naltrexone recipients developed elevations of serum transaminases (i.e., peak ALT val ...
... controlled study in which naltrexone hydrochloride was administered to obese subjects at a dose approximately five-fold that recommended for the blockade of opiate receptors (300 mg per day). In that study, 5 of 26 naltrexone recipients developed elevations of serum transaminases (i.e., peak ALT val ...
November 2015 – Positive Recommendations (Word 80KB)
... breakthrough pain in patients undergoing palliative care for cancer. The recommendation was made on a cost-minimisation basis with fentanyl citrate sublingual tablets. The equi-effective doses were not estimated. However, an assumption of one dose per episode of breakthrough pain was considered reas ...
... breakthrough pain in patients undergoing palliative care for cancer. The recommendation was made on a cost-minimisation basis with fentanyl citrate sublingual tablets. The equi-effective doses were not estimated. However, an assumption of one dose per episode of breakthrough pain was considered reas ...
Abilify ® (Aripiprazole Tablets) - Bristol
... ABILIFY belongs. Safety concerns of this class include: weight gain; hyperlipidemia; hyperglycaemia; Tardive Dyskinesia; and Neuroleptic Malignant Syndrome (see WARNINGS AND PRECAUTIONS, ADVERSE REACTIONS). ABILIFY should only be prescribed in patients with MDD by clinicians who are aware of the imp ...
... ABILIFY belongs. Safety concerns of this class include: weight gain; hyperlipidemia; hyperglycaemia; Tardive Dyskinesia; and Neuroleptic Malignant Syndrome (see WARNINGS AND PRECAUTIONS, ADVERSE REACTIONS). ABILIFY should only be prescribed in patients with MDD by clinicians who are aware of the imp ...
files - NIHR
... This issue of Health Technology Assessment contains a project originally commissioned by the MRC but managed by the Efficacy and Mechanism Evaluation Programme. The EME programme was created as part of the National Institute for Health Research (NIHR) and the Medical Research Council (MRC) coordinat ...
... This issue of Health Technology Assessment contains a project originally commissioned by the MRC but managed by the Efficacy and Mechanism Evaluation Programme. The EME programme was created as part of the National Institute for Health Research (NIHR) and the Medical Research Council (MRC) coordinat ...
Full Topic PDF
... It’s Sunday morning. You’ve just discharged the last Saturday night warrior from the ED when you get a call that the local EMS crew is bringing in a woman who has had a syncopal episode at church. When the crew arrives, you get a typical story from the paramedic. “She’s a 44-year-old woman who was s ...
... It’s Sunday morning. You’ve just discharged the last Saturday night warrior from the ED when you get a call that the local EMS crew is bringing in a woman who has had a syncopal episode at church. When the crew arrives, you get a typical story from the paramedic. “She’s a 44-year-old woman who was s ...
the Work in Progress abstracts
... progressive disease, or other demographic characteristics that may be associated with a lower likelihood of participation in clinical trials. Several currently recruiting registry efforts, while representing an improvement, also either rely on self-selection by PALS or have limited capacity to ensur ...
... progressive disease, or other demographic characteristics that may be associated with a lower likelihood of participation in clinical trials. Several currently recruiting registry efforts, while representing an improvement, also either rely on self-selection by PALS or have limited capacity to ensur ...
Monitoring asthma in children
... concept of asthma control is central to all asthma guidelines and the level of control is defined as the extent to which features of asthma are controlled by daily therapy, for example exertional symptoms, night awakening, the use of reliever medication and the ability to carry out daily activities. ...
... concept of asthma control is central to all asthma guidelines and the level of control is defined as the extent to which features of asthma are controlled by daily therapy, for example exertional symptoms, night awakening, the use of reliever medication and the ability to carry out daily activities. ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These
... Clinically significant hyponatremia (sodium <125 mmol/L) can develop during oxcarbazepine use. In the 14 controlled epilepsy studies 2.5% of oxcarbazepine-treated patients (38/1,524) had a sodium of less than 125 mmol/L at some point during treatment, compared to no such patients assigned placebo or ...
... Clinically significant hyponatremia (sodium <125 mmol/L) can develop during oxcarbazepine use. In the 14 controlled epilepsy studies 2.5% of oxcarbazepine-treated patients (38/1,524) had a sodium of less than 125 mmol/L at some point during treatment, compared to no such patients assigned placebo or ...
SURVEILLANCE OF ANTIBIOTIC CONSUMPTION AND ANTIBIOTIC RESISTANCE IN SWEDISH INTENSIVE CARE UNITS
... was not a major problem. Signs of crosstransmission with non-multiresistant bacteria were observed, indicating a hygiene problem and identifying simple improvements that could be made in patient care guidelines and barrier precautions. A need for better follow up of prescribed antibiotics was eviden ...
... was not a major problem. Signs of crosstransmission with non-multiresistant bacteria were observed, indicating a hygiene problem and identifying simple improvements that could be made in patient care guidelines and barrier precautions. A need for better follow up of prescribed antibiotics was eviden ...
General requirements for labels for medicines RIS
... over 16 years ago, TGO 69 mandates information that must be on labels and the format and placement in which it must be presented. Examples of information required by TGO 69 include the name of the medicine, the name of the active ingredient (e.g. paracetamol) and its strength or quantity, storage re ...
... over 16 years ago, TGO 69 mandates information that must be on labels and the format and placement in which it must be presented. Examples of information required by TGO 69 include the name of the medicine, the name of the active ingredient (e.g. paracetamol) and its strength or quantity, storage re ...
J Medical Treatment of Juvenile Idiopathic Arthritis CLINICAL REVIEW
... using MEDLINE, EMBASE, the Cochrane database, and abstracts from recent rheumatology and pediatric scientific meetings. Study Selection Randomized controlled trials and open studies including at least 10 patients for medications without controlled trials. Data Extraction For studies after 1997, the ...
... using MEDLINE, EMBASE, the Cochrane database, and abstracts from recent rheumatology and pediatric scientific meetings. Study Selection Randomized controlled trials and open studies including at least 10 patients for medications without controlled trials. Data Extraction For studies after 1997, the ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These
... drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest ...
... drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest ...